These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 19671845)

  • 1. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
    Adam L; Zhong M; Choi W; Qi W; Nicoloso M; Arora A; Calin G; Wang H; Siefker-Radtke A; McConkey D; Bar-Eli M; Dinney C
    Clin Cancer Res; 2009 Aug; 15(16):5060-72. PubMed ID: 19671845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
    Liu L; Qiu M; Tan G; Liang Z; Qin Y; Chen L; Chen H; Liu J
    J Transl Med; 2014 Nov; 12():305. PubMed ID: 25367080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
    Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
    Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
    Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
    J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
    Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
    Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.
    Vetter G; Saumet A; Moes M; Vallar L; Le Béchec A; Laurini C; Sabbah M; Arar K; Theillet C; Lecellier CH; Friederich E
    Oncogene; 2010 Aug; 29(31):4436-48. PubMed ID: 20543867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gambogic Acid Improves Cisplatin Resistance of Bladder Cancer Cells through the Epithelial-Mesenchymal Transition Pathway Mediated by the miR-205-5p/ZEB1 Axis.
    Mei Y; Xu J; Li W; Chen S
    Ann Clin Lab Sci; 2024 May; 54(3):354-362. PubMed ID: 39048172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
    Narita M; Shimura E; Nagasawa A; Aiuchi T; Suda Y; Hamada Y; Ikegami D; Iwasawa C; Arakawa K; Igarashi K; Kuzumaki N; Yoshioka Y; Ochiya T; Takeshima H; Ushijima T; Narita M
    PLoS One; 2017; 12(2):e0172115. PubMed ID: 28225782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.
    Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ
    J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.
    McConkey DJ; Choi W; Marquis L; Martin F; Williams MB; Shah J; Svatek R; Das A; Adam L; Kamat A; Siefker-Radtke A; Dinney C
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):335-44. PubMed ID: 20012924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
    Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
    Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
    Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
    J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Wu CL; Ho JY; Chou SC; Yu DS
    Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
    Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
    Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.
    Dyrskjøt L; Ostenfeld MS; Bramsen JB; Silahtaroglu AN; Lamy P; Ramanathan R; Fristrup N; Jensen JL; Andersen CL; Zieger K; Kauppinen S; Ulhøi BP; Kjems J; Borre M; Orntoft TF
    Cancer Res; 2009 Jun; 69(11):4851-60. PubMed ID: 19487295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling.
    Xue L; Su D; Li D; Gao W; Yuan R; Pang W
    Cell Biochem Biophys; 2015 May; 72(1):185-90. PubMed ID: 25542369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation.
    Costa V; Carina V; Raimondi L; De Luca A; Bellavia D; Conigliaro A; Salamanna F; Alessandro R; Fini M; Giavaresi G
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
    Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
    Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.